Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.
Accepted 2025-05-12 00:00:00 ET · period of report 2025-05-08 · accession 0001735276-25-000060 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-12 | 2025-05-08 | ALNY | Sigal Charles Elliott | Dir | A - Grant | $0.00 | +775 | 775 | New | $0 |
| D | 2025-05-12 | 2025-05-08 | ALNY | Sigal Charles Elliott | Dir | A - Grant | $0.00 | +1,558 | 1,558 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-08 | A | A | 775 | $0.00 | 775 | D | — | — | (F1) These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. |
| 2 | Derivative | Stock Option (right to buy) | 2025-05-08 | A | A | 1,558 | $0.00 | 1,558 | D | $258.35 · 2026-05-08 to 2035-05-08 | 1,558 Common Stock | (F3) The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. |